Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/5/2020
SIETES contiene 93010 citas

 
 
<< anterior 21 a 40 de 209 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Rutten FH, Groenwold RHH. ß blockers for adults with chronic obstructive pulmonary disease. BMJ 2013;347:f7050. [Ref.ID 97172]
22.Tiene citas relacionadas Cita con resumen
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith Jr SC, Svetkey LP, Taler SJ, Townsend RR, Wright Jr JT, Narva AS, Ortiz E. 2014 evidence based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. [Ref.ID 97094]
23.Tiene citas relacionadas
Bauchner H, Fontanarosa PB, Golub RM. Updated guidelines for management of high blood pressure: recommendation, review, and responsibility. JAMA 2014;311:477-8. [Ref.ID 97092]
24.Tiene citas relacionadas
Peterson ED, Gaziano JM, Greenland P. Recommendations for treating hypertension: what are the right goals and purposes?. JAMA 2014;311:474-6. [Ref.ID 97091]
26.Tiene citas relacionadas
Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. The authors reply. N Engl J Med 2013;369:2459. [Ref.ID 96682]
27.Tiene citas relacionadas
Vandecasteele SJ, De Vriese AS. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2458-9. [Ref.ID 96681]
28.Tiene citas relacionadas Cita con resumen
Cherney D, Maahs DM. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2458. [Ref.ID 96680]
29.Tiene citas relacionadas Cita con resumen
Tavares Jr AR. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2457-8. [Ref.ID 96679]
30. Cita con resumen
Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, Sequist ER, Reddy MS, Lewis CE, Oates TW, Tripathy D, Katancik JA, Orlander PR, Paquette DW, Hanson NQ, Tsai MY. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA 2013;310:2523-32. [Ref.ID 96673]
31. Cita con resumen
Liu C-H, Huang C-F, Liu C-J, Dai C-Y, Liang C-C, Huang J-F, Hung P-H, Tsai H-B, Tsai M-K, Chen S-I, Lin J-W, Yang S-S, Su T-H, Yang H-C, Chen P-J, Chen D-S, Chuang W-L, Yu M-L, Kao J-H. Pegylated Interferon-a2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial. Ann Intern Med 2013;159:729-38. [Ref.ID 96651]
32. Cita con resumen
Poluzzi E, Piccinni C, Sangiorgi E, Clo M, Tarricone I, Menchetti M, De Ponti F. Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence. Eur J Clin Pharmacol 2013;69:2095-101. [Ref.ID 96640]
33. Cita con resumen
Anónimo. FDA approves Sovaldi for chronic hepatitis C. U.S. Food and Drug Administration 2013:6 de diciembre. [Ref.ID 96566]
34.Tiene citas relacionadas Cita con resumen
Fazel S, Wolf A, Lagnström N, Newton CR, Lichtenstein P. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet 2013;382:1646-54. [Ref.ID 96560]
35.Tiene citas relacionadas
Sander JW. Comorbidity and premature mortality in epilepsy. Lancet 2013;382:1618-9. [Ref.ID 96557]
36.Tiene citas relacionadas Cita con resumen
Hunt LP, Ben-Shlomo Y, Clark EM, Dieppe P, Judge A, MacGregor AJ, Tobias JH, Vernon K, Blom AW, on behalf of the National Joint Registry for England Wales and Northern Ireland. 90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. Lancet 2013;382:1097-104. [Ref.ID 96311]
37.Tiene citas relacionadas Cita con resumen
Issa K, Mont MA. Total hip replacement: mortality and risks. Lancet 2013;382:1074-6. [Ref.ID 96310]
38.Enlace a cita original Cita con resumen
Martínez Velilla N. El desafío terapéutico de la multimorbilidad. Boletín de Información Farmacoterapéutica de Navarra 2013;21:1-12. [Ref.ID 96245]
39. Cita con resumen
Rawlins M. NICE times: a valedictory dispatch. Lancet 2013;381:2225-7. [Ref.ID 95752]
Seleccionar todas
 
<< anterior 21 a 40 de 209 siguiente >>